HAVCR2 and B-cell chronic lymphocytic leukemia: Four out of six donors (three HDs and one untreated CLL patient) had higher levels of TCM, HLA-DR+, Tim-3+, CD19+, and CD34+ CART cells and four out of six (two HDs and two patients) presented a higher number of CD4+ CD8+ CART cells.